SOAR MORE, LLC – Trademark Portfolio
Entity Type: 16
SOAR MORE, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include MANLAND, FREEZE THE FAT, MARINA MANLAND, PATIENTS FOR LIFE, and INTERNATIONALLY RENOWNED, INDIVIDUALLY FOCUSED. The owner is based in SHERMAN OAKS, CA.
13455 VENTURA BLVD, STE. 208
SHERMAN OAKS, CA 91423
Showing of trademarks Trademarks
Trademark Classifications
SOAR MORE, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does SOAR MORE, LLC have?
SOAR MORE, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 3 cancelled.
What trademark classes does SOAR MORE, LLC file in?
SOAR MORE, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are SOAR MORE, LLC's most well-known trademarks?
SOAR MORE, LLC's registered trademark portfolio includes well-known marks such as MANLAND, FREEZE THE FAT, MARINA MANLAND, PATIENTS FOR LIFE, and INTERNATIONALLY RENOWNED, INDIVIDUALLY FOCUSED. These are among 6 currently registered trademarks in the portfolio.
What is SOAR MORE, LLC's trademark registration success rate?
SOAR MORE, LLC has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.